Candel Therapeutics, Inc.
Ticker: 1841387
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY22 | Q3 FY22 | Q2 FY22 | Q2 FY22 | Q1 FY22 | Q1 FY22 | Q3 FY21 | Q2 FY21 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03 |
| Total Income | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03+0.0% | 0.03 |
| EXPENSES | ||||||||
| Expenditure | 8.91+0.0% | 8.91+1.5% | 8.78+0.0% | 8.78-2.7% | 9.02+0.0% | 9.02+11.9% | 8.06+51.2% | 5.33 |
| Tax | 0.00 | — | — | — | 0.00 | — | — | — |
| PROFIT | ||||||||
| Net Profit | -8.69+0.0% | -8.69-109.4% | -4.15+0.0% | -4.15-377.0% | -0.87+0.0% | -0.87+94.6% | -16.16+5.4% | -17.08 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.30+0.0% | -0.30-114.3% | -0.14+0.0% | -0.14-366.7% | -0.03 | — | — | — |
Corporate Events
Board MeetingCADL
20266Jul
Board Meeting
Chief Commercial Officer Appointment — Mark Sims appointed a…
SEC Filing ↗ Board MeetingCADL
202623Jun
Board Meeting
Election of four Class II directors and ratification of KPMG…
SEC Filing ↗ Board MeetingCADL
202612Jun
Board Meeting
CFO Employment Agreement — Candel Therapeutics entered into …
SEC Filing ↗